Clinical Trial Update: Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)

View source ↗

Summary

A recruiting study evaluating genomic and methylation markers to predict resistance to chemo-immunotherapy in small cell lung cancer and large cell neuroendocri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large Cell Neuroendocrine Carcinoma of the Lung
• Small Cell Lung Cancer

Snippet

Sponsor: Oncology Center of Biochemical Education And Research | Conditions: Small Cell Lung Cancer, Large Cell Neuroendocrine (NE) Tumors | Status: RECRUITING